Elie Abed, MD
Endocrinology, Diabetes & Metabolism · Tulsa, OKNPI 1235579202
Payments from drug & device makers
Across 553 payments — averaging $49.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$18K
- Lilly USA, LLC$1K
- Abbott$868
- AstraZeneca$795
- Novo Nordisk$672
- Bayer$630
- plus $5K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 17 | $17,905 |
| Lilly USA, LLC | 76 | $1,218 |
| Abbott | 53 | $868 |
| AstraZeneca(2 entities) | 26 | $795 |
| Novo Nordisk | 48 | $672 |
| Bayer | 38 | $630 |
| Dexcom, Inc. | 46 | $570 |
| Novartis | 26 | $445 |
| Boehringer Ingelheim | 26 | $424 |
| Esperion Therapeutics, Inc. | 16 | $418 |
| Amgen | 26 | $387 |
| Amneal Pharmaceuticals LLC | 16 | $327 |
| Insulet Corporation | 10 | $326 |
| Xeris Pharmaceuticals, Inc. | 16 | $315 |
| Tandem Diabetes Care, Inc. | 12 | $301 |
| Corcept Therapeutics | 14 | $240 |
| Mannkind Corporation | 14 | $239 |
| Kyowa Kirin, Inc. | 8 | $184 |
| AbbVie | 9 | $150 |
| Johnson & Johnson | 4 | $131 |
| Antares Pharma, Inc. | 8 | $127 |
| Currax Pharmaceuticals LLC | 8 | $123 |
| Recordati_rare_diseases_inc. | 4 | $99 |
| Astellas Pharma US Inc | 4 | $92 |
| BETA Bionics, Inc. | 3 | $70 |
| Medtronic | 3 | $52 |
| Intra-sana Laboratories | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Rhythm Pharmaceuticals, Inc. | 1 | $31 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Gilead | 1 | $25 |
| Sequel Med Tech, LLC | 1 | $23 |
| Surmodics, Inc. | 1 | $16 |
| Halozyme Inc | 1 | $14 |
| Merck | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
How this compares
$27,485 in reported general payments places this provider in the 85th percentile of 61 endocrinology, diabetes & metabolism providers in Oklahoma.
See all endocrinology, diabetes & metabolism providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Tulsa
- Cristin BrunsTulsa$159K
- Donald AspensonTulsa$153K
- Hanna FoggTulsa$25K
- Mario Bustos RodriguezTulsa$19K
- Lauren LabryerTulsa$12K
- Vishnu Priya PulipatiTulsa$8K
- Maria VargasTulsa$7K
- Christian HansonTulsa$4K
- Miguel Jara PalaciosTulsa$4K
- Deepa PhilipTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.